Document is current
Any future updates will be listed below
-
Authors
Leung, Chak Ming
de Haan, Pim https://orcid.org/0000-0002-3481-8594
Ronaldson-Bouchard, Kacey
Kim, Ge-Ah https://orcid.org/0000-0001-6659-7039
Ko, Jihoon https://orcid.org/0000-0002-6555-3728
Rho, Hoon Suk
Chen, Zhu
Habibovic, Pamela https://orcid.org/0000-0001-8249-5155
Jeon, Noo Li
Takayama, Shuichi https://orcid.org/0000-0002-4385-9080
Shuler, Michael L. https://orcid.org/0000-0002-4662-317X
Vunjak-Novakovic, Gordana
Frey, Olivier
Verpoorte, Elisabeth https://orcid.org/0000-0002-6616-4134
Toh, Yi-Chin https://orcid.org/0000-0002-4105-4852
- License Information
-
More Information
Article History
Accepted: 22 March 2022
First Online: 12 May 2022
Competing interests
: O.F. is member of the management team of InSphero commercializing 3D organ systems. K.R.-B. and G.V.-N. are co-founders of Tara Biosystems, a Columbia University start-up company commercializing organs-on-a-chip with human heart muscle. M.L.S. is CEO and President of Hesperos, Inc. All other authors declare no competing interests.
